Welcome to our dedicated page for Universal Ins Hldgs SEC filings (Ticker: UVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Universal Insurance Holdings, Inc. (NYSE: UVE) SEC filings page provides access to the company’s regulatory disclosures as a U.S. property and casualty insurance holding company. Universal files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K with the Securities and Exchange Commission, covering its operations in personal residential homeowners lines of business and related insurance services.
Recent Form 8-K filings for Universal Insurance Holdings include announcements of quarterly financial results, share repurchase authorizations and cash dividends on common stock. Earnings-related 8-Ks incorporate press releases that present GAAP and non-GAAP financial measures, such as total revenues, net income available to common stockholders, core revenue, adjusted net income, diluted adjusted earnings per share, adjusted operating income, adjusted book value per share and adjusted return on common equity. These filings also summarize key underwriting metrics, including direct premiums written, net premiums earned, ceded premium ratio, loss ratio, expense ratio and combined ratio.
Other 8-K filings report Board actions authorizing multi-year share repurchase programs and declaring regular and special cash dividends. These documents describe the size and duration of repurchase authorizations, the intention to conduct repurchases in accordance with Rule 10b-18 under the Securities Exchange Act of 1934 and the company’s insider trading policy, and the per-share amounts of declared dividends.
On this page, Stock Titan pairs Universal’s SEC filings with AI-powered summaries that explain the main points of each document in plain language. Users can quickly see what Universal reported in its latest 10-K or 10-Q, how management describes non-GAAP financial measures and key performance indicators, and what material events are disclosed in 8-Ks. The filings feed updates as new documents are posted to EDGAR, helping investors follow Universal’s financial reporting, reinsurance-related disclosures and capital management decisions without reading every line of each filing.
A holder of UVE common stock filed an amended notice under Rule 144 to sell 25,000 shares through Wells Fargo Clearing Services on or about 12/30/2025 on the NYSE, with an aggregate market value of $844,398.16. The filing notes that 28,048,881 shares of the same class were outstanding. It also reports that the Stephen Donaghy Trust previously sold 25,000 common shares of UVE on 12/29/2025 for gross proceeds of $851,779.94. The seller represents that they do not know of any material adverse, non‑public information about the issuer’s current or prospective operations.
A shareholder identified as the Stephen Donaghy Trust has filed a Form 144 notice relating to common shares of UVE. The filing covers an intended sale of 25,000 common shares through Wells Fargo Clearing Services on the NYSE around 12/30/2025, with an aggregate market value of 844,398.16. These 25,000 shares were originally acquired on 11/15/2018 via an open market purchase paid in cash. The notice also reports that the Stephen Donaghy Trust sold 25,000 common shares of UVE on 12/29/2025 for gross proceeds of 851,779.94. By signing, the seller represents that they are not aware of any undisclosed material adverse information about UVE’s operations.
A shareholder of UVE has filed a notice of proposed sale of 25,000 shares of common stock under Rule 144. The shares are expected to be sold on the NYSE through Wells Fargo Clearing Services, with an indicated aggregate market value of $851,779.94. The filing notes that 28,048,881 shares of this class were outstanding.
The securities to be sold were originally acquired on 11/15/2018 in an open market purchase paid in cash. By signing the notice, the seller represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 requirements.
Universal Insurance Holdings disclosed equity transactions by its Principal Accounting Officer, reported as a single filer. The officer received and exercised restricted stock units (RSUs) that convert into shares of common stock, and had shares withheld to cover taxes.
On December 20, 2024, the officer was granted 4,000 RSUs, each representing one share of common stock, vesting in three approximately equal installments on each of the first three anniversaries of the grant date, subject to continued employment. On December 19, 2025, 1,667 RSUs were exercised at an exercise price of $0, and 406 shares of common stock were withheld at $33.89 per share to satisfy tax obligations. On December 20, 2025, 1,334 RSUs were exercised at $0, with 325 shares withheld at $34.63 per share for taxes.
After these transactions, the officer directly owned 7,312 shares of common stock and held remaining RSU awards as reported in the derivative securities table.
Universal Insurance Holdings, Inc. Executive Chairman and Director Sean P. Downes reported selling 20,000 shares of common stock on 12/19/2025 at a weighted average price of $33.8158 per share. The shares were sold in multiple transactions at prices ranging from $33.46 to $34.43.
After this sale, Downes beneficially owns 1,243,512 shares directly, plus 2,000 shares held indirectly by his spouse and 18,000 shares held indirectly by his children.
UVE filed a notice of proposed insider share sales under Rule 144. The filing covers a planned sale of 20,000 shares of common stock through Raymond James & Associates on the NYSE, with an aggregate market value of $680,000. The filing notes that 28,048,000 shares of common stock were outstanding at the time of the notice.
The 20,000 shares to be sold were originally acquired from the issuer on 03/13/2014 as compensation in lieu of cash, with payment also dated 03/13/2014 and described as cash. Over the past three months, the same seller disposed of 20,000 shares of common stock on 10/29/2025 for gross proceeds of $627,062.05 and another 20,000 shares on 11/25/2025 for gross proceeds of $668,114.05.
Universal Insurance Holdings, Inc. reported an insider equity transaction by its Chief Financial Officer, Frank Wilcox. On 12/16/2025, 812 shares of common stock were disposed of at a price of $33.19 per share under transaction code "F," which indicates shares were withheld to cover taxes. The note explains these shares were withheld to satisfy tax obligations related to the vesting of 3,333 restricted stock units on that date.
Following this tax-withholding transaction, Wilcox beneficially owned 132,620 shares of Universal Insurance Holdings common stock in direct ownership. The filing reflects an administrative equity compensation event rather than an open-market trade.
Universal Insurance Holdings, Inc. reported an insider share withholding by its Principal Accounting Officer, Gary Ropiecki. On December 16, 2025, 406 shares of common stock were withheld at a price of $33.19 per share to cover tax obligations related to the vesting of 1,666 restricted stock units (RSUs).
Following this tax-related transaction, Ropiecki directly beneficially owns 5,042 shares of Universal Insurance Holdings common stock. The filing reflects an administrative equity compensation event rather than an open‑market purchase or sale.
Universal Insurance Holdings, Inc. (UVE) director and officer reports tax withholding share disposition. A reporting person who serves as both a director and as CIO & CAO filed a Form 4 for a transaction dated December 16, 2025.
The filing shows that 406 shares of common stock were disposed of at $33.19 per share under transaction code "F", which indicates shares were withheld to cover taxes. An accompanying note explains these shares were withheld to satisfy tax withholding obligations related to the vesting of 1,666 restricted stock units (RSUs) on that date. Following the transaction, the insider beneficially owns 9,132 shares of Universal Insurance common stock, held directly.
Universal Insurance Holdings, Inc. reported an equity compensation grant to an executive. On December 5, 2025, the company awarded 3,500 restricted stock units (RSUs) tied to its common stock to its Principal Accounting Officer, who is an officer of the company and the sole reporting person on this filing. Each RSU represents a contingent right to receive one share of Universal Insurance common stock.
The RSUs vest in three approximately equal installments on each of the first three anniversaries of the grant date, starting from December 5, 2025, and require the executive to remain employed through each vesting date. This filing is a standard Form 4 disclosure, showing ongoing use of stock-based compensation to align executive interests with shareholders over time.